Abstract
A synthetic route to BIX-01294 was designed by means of retrosynthetic analysis and convergent synthesis. Using 2-amino-4,5-dimethoxybenzoic acid and urea as the starting materials, BIX-01294 was synthesized in the four following steps: cyclization, chlorination and two steps of ammonolysis. In contrast to the previously described approaches to BIX-01294, our final step conditions do not require microwave irradiation, utilize cheap and simple methanesulfonic acid as a catalyst to promote the synthesis of the target BIX-01294 under mild conditions (PrnOH, reflux, 5 h) in 75.5% yield. The overall yield of BIX-01294 over four steps was 26.4%.
Similar content being viewed by others
References
H. Cao, L. Li, D. Yang, L. Zeng, X. Yewei, B. Yu, G. Liao, J. Chen, Eur. J. Med. Chem., 2019, 179, 537; DOI: https://doi.org/10.1016/j.ejmech.2019.06.072.
C. W. Luo, J. Y. Wang, W. C. Hung, G. Peng, Y. L. Tsai, T. M. Chang, C. Y. Chai, C. H. Lin, M. R. Pan, Radiother. Oncol., 2017, 3, 395e402; DOI: https://doi.org/10.1016/j.radonc.2017.03.002.
Y. Shinkai, M. Tachibana, Genes Dev., 2011, 8, 781; DOI: https://doi.org/10.1101/gad.2027411.
A. S. Guo, Y. Q. Huang, X. D. Ma, Mol. Med. Rep., 2016, 5, 4613; DOI: https://doi.org/10.3892/mmr.2016.5815.
S. Kubicek, R. J. O’Sullivan, E. M. August, Mol. Cell, 2007, 25, 473; DOI: https://doi.org/10.1016/j.molcel.2007.01.017.
Y. Chang, X. Zhang, J. R. Horton, Nat. Struct. Mol. Biol., 2009, 3, 312; DOI: https://doi.org/10.1038/nsmb.1560.
K. A. Chase, B. Feiner, M. J. Ramaker, E. Hu, C. Rosen, R. P. Sharma, PLoS one, 2019, 14, e0216463; DOI: https://doi.org/10.1371/journal.pone.0216463.
Y. F. Wang, J. Zhang, Y. Su, Y. Y. Shen, D.X. Jiang, Y. Y. Hou, M. Y. Geng, J. Ding, Y. Chen, Nat. Commun., 2017, 8, 274; DOI: https://doi.org/10.1038/s41467-017-00350-9.
L. Zang, S. M. Kondengaden, Q. Zhang, X. Li, D. K. Sigalapalli, S. M. Kondengadan, K. Huang, K. K. Li, S. Li, Z. Xiao, L. Wen, H. Zhu, B. N. Babu, L. Wang, F. Che, P. G. Wang, Oncotarget, 2017, 8, 63187; DOI: https://doi.org/10.18632/oncotarget.18730.
H. S. Cho, J. D. Kelly, S. Hayami, G. Toyokawa, M. Takawa, M. Yoshimatsu, T. Tsunoda, H. I. Field, D. E. Neal, B. A. Ponder, Y. Nakamura, R. Hamamoto, Neoplasia, 2011, 13, 676; DOI: https://doi.org/10.1593/neo.11512.
Y. Huang, Y. Zou, L. Lin, Leuk. Res., 2017, 62, 34; DOI: https://doi.org/10.1016/j.leukres.2017.09.015.
M. Yokoyama, T. Chiba, Y. Zen, Oncotarget, 2017, 13, 21315; DOI: https://doi.org/10.18632/oncotarget.15528.
A. Vitkeviciene, S. Baksiene, V. Borutinskaite, R. Navakauskiene, Eur. J. Pharm., 2018, 838, 32; DOI: https://doi.org/10.1016/j.ejphar.2018.09.005.
L. Xu, X. Gao, Pu Yang, W. Sang, J. Jiao, M. Niu, M. Liu, Y. Qin, D. Yan, X. Song, C. Sun, Yu Tian, F. Zhu, X. Sun, L. Zeng, Zh. Li, K. Xu, J. Cancer, 2021, 12, 1011; DOI: https://doi.org/10.7150/jca.48310.
F. Liu, X. Chen, A. Allali-Hassani, A. M. Quinn, T. J. Wigle, G. A. Wasney, A. Dong, G. Senisterra, I. Chau, A. Siarheyeva, J. L. Norris, D. B. Kireev, A. Jadhav, J. M. Herold, W. P. Janzen, C. H. Arrowsmith, S. V. Frye, P. J. Brown, A. Simeonov, M. Vedadi, J. Jin, J. Med. Chem., 2010, 53, 5844; DOI: https://doi.org/10.1021/jm100478y.
S. Sundriyal, N. A. Malmquist, J. Caron, S. Blundell, F. Liu, X. Chen, N. Srimongkolpithak, J. Jin, S. A. Charman, A. Scherf, M. J. Fuchter, ChemMedChem., 2014, 9, 2360; DOI: https://doi.org/10.1002/cmdc.201402098.
S. Sundriyal, P. B. Chen, A. S. Lubin, MedChemComm, 2017, 8, 1069; DOI: https://doi.org/10.1039/c7md00052a.
P. G. Wang, M. S. Kondengaden, Q. Zhang, L. Zang, Int. Pat. Appl. WO 2018/005799 A1, 2018.
S. A. Yakukhnov, V. P. Ananikov, Adv. Synth. Catal., 2019, 361, 4781; DOI: https://doi.org/10.1002/adsc.201900686.
R. S. Vardanyan, V. J. Hruby, Pat. Appl. US 20180235949 A1, 2018.
S. Devarasetty, R. Nunna, R. Janni, V. V. Pothuri, R. R. Suraparaju, Asian J. Chem., 2018, 30, 775; DOI: https://doi.org/10.14233/ajchem.2018.20985.
M. L. de Castro Barbosa, L. M. Lima, R. Tesch, C. M. R. Sant’Anna, F. Totzke, M. H. G. Kubbutat, C. Schächtele, S. A. Laufer, E. J. Barreiro, Eur. J. Med. Chem., 2014, 71, 1; DOI: https://doi.org/10.1016/j.ejmech.2013.10.058.
G. Stork, S. M. McElvain, J. Am. Chem. Soc., 1946, 68, 1053; DOI: https://doi.org/10.1021/ja01210a041.
A. S. Mehanna, J. Y. Kim, Bioorg. Med. Chem., 2005, 13, 4323; DOI: https://doi.org/10.1016/j.bmc.2005.04.012.
N. Sundaraganesan, G. Elango, C. Meganathan, B. Karthikeyan, M. Kurt, Mol. Simul., 2009, 35, 705; DOI: https://doi.org/10.1080/08927020902873992.
G. Kumaraswamy, N. Jena, M. N. V. Sastry, B. A. Kumar, Org. Prep. Proced. Int., 2004, 36, 341; DOI: https://doi.org/10.1080/00304940409458676.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was funded by the Liaoning Revitalization Talents Program (XLYC1908031, China), Major Basic Research Project of Natural Science Foundation of Shandong Province (ZR2018ZC1056, China), Taishan Industry Leading Talents Project (NO: 2018TSCYCX-17).
No human or animal subjects were used in this research.
The authors declare no competing interests.
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 11, pp. 2489–2494, November, 2022.
Rights and permissions
About this article
Cite this article
Shi, Y., Chen, Y., Chen, L. et al. A mild protocol for the synthesis of N-methyltransferase G9a inhibitor BIX-01294. Russ Chem Bull 71, 2489–2494 (2022). https://doi.org/10.1007/s11172-022-3678-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-022-3678-9